Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page
25
Current page
30
8-K File 001-36548

FORM 8-K

Filing date
08 Feb 2018
Reporting date
06 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jan 2018
Reporting date
25 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A filing

Filing date
29 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jan 2018
Reporting date
22 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jan 2018
Reporting date
10 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88393

PRIMARY DOCUMENT

Filing date
05 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
04 Jan 2018
Reporting date
03 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207876

424B5

Filing date
04 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-207876

FWP

Filing date
03 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jan 2018
Reporting date
28 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207876

424B5

Filing date
02 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K

Filing date
29 Dec 2017
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88393

SC 13G/A

Filing date
08 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88393

MS INITIAL

Filing date
07 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Dec 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .